Verrucarin A Induces Apoptosis Through ROS-Mediated EGFR/MAPK/Akt Signaling Pathways in MDA-MB-231 Breast Cancer Cells

Journal of Cellular Biochemistry

Volumn 115, Issue 11, 2014, Pages 2022-2032

  Palanivel, Kandasamy ^a   Kanimozhi, Veerasamy ^a   Kadalmani, Balamuthu ^a   Akbarsha, Mohammad Abdulkader ^a  

^a BHARATHIDASAN UNIVERSITY   (India)

Author keywords

APOPTOSIS; EPIDERMAL GROWTH FACTOR RECEPTOR; MAPK; REACTIVE OXYGEN SPECIES; VERRUCARIN A

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACETYLCYSTEINE; CASPASE 3; CYTOCHROME C; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BCL 2; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN RECEPTOR; VERRUCARIN A; ANTINEOPLASTIC ANTIBIOTIC; TRICHOTHECENE DERIVATIVE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOSOL; DNA FRAGMENTATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INTRACELLULAR SPACE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; BREAST TUMOR; CELL PROLIFERATION; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE SIGNALING SYSTEM; MEMBRANE POTENTIAL, MITOCHONDRIAL; REACTIVE OXYGEN SPECIES; TRICHOTHECENES;

EID: 84941142084     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24874     Document Type: Article

References (24)

1. Aggarwal BB,. 2004. Nuclear factor-kappa B: The enemy within. Cancer Cell 6: 203-208.
2. Andersen B, Nielsen KF, Jarvis BB,. 2002. Characterization of Stachybotrys from water-damaged buildings based on morphology, growth, and metabolite production. Mycologia 94: 392-403.
3. Aroui S, Brahim S, De Waard M, Bréard J, Kenani A,. 2009. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB-231. Cancer Lett 285: 28-38.
4. Chen YW, Huang CF, Yang CY, Yen CC, Tsai KS, Liu SH,. 2010. Inorganic mercury causes pancreatic beta-cell death via the oxidative stress induced apoptotic and necrotic pathways. Toxicol Appl Pharmacol 243: 323-331.
5. Cowan KJ, Storey KB,. 2003. Mitogen-activated protein kinases: new signalling pathways functioning in cellular responses to environmental stress. J Exp Biol 206: 1107-1115.
6. Galbaugh T, Cerrito MG, Jose CC, Cutler ML,. 2006. EGF-induced activation of Akt results in mTOR-dependent p70S6 kinase phosphorylation and inhibition of HC11 cell lactogenic differentiation. BMC Cell Biol 7: 34.
7. Kamata H, Hirata H,. 1999. Redox regulation of cellular signalling. Cell Signal 11: 1-14.
8. Lawlor MA, Alessi DR,. 2001. PKB/Akt: A key mediator of cell proliferation, survival and insulin responses? J Cell Sci 114: 2903-2910.
9. Lee JJ, Swain SM,. 2005. Development of novel chemotherapeutic agents to evade the mechanisms of multidrug resistance (MDR). Semin Oncol 32: 22-26.
10. Looyenga BD, Hutchings D, Cherni I, Kingsley C, Weiss GJ, MacKeigan JP,. 2012. STAT3 is activated by JAK2 independent of key oncogenic driver mutations in non-small cell lung carcinoma. PLoS One 7: e30820.
11. Nahta R, Yuan LX, Du Y, Esteva FJ,. 2007. Lapatinib induces apoptosis in trastuzumab-resistant breast cancer cells: Effects on insulin-like growth factor I signaling. Mol Cancer Ther 6 (2): 667-674.
12. Nestal de Moraes G, Vasconcelos FC, Delbue D, Mognol GP, Sternberg C, Viola JP, Maia RC,. 2013. Doxorubicin induces cell death in breast cancer cells regardless of survivin and XIAP expression levels. Eur J Cell Biol 92: 247-256.
13. Oda T, Namikoshi M, Akano K, Kobayashi H, Honma Y, Kasahara T,. 2005. Verrucarin A inhibition of MAP kinase activation in a PMA-stimulated promyelocytic leukemia cell line. Mar Drugs 3: 64-73.
14. Palanivel K, Kanimozhi V, Kadalmani B, Akbarsha MA,. 2013. Verrucarin A, a protein synthesis inhibitor, induces growth inhibition and apoptosis in breast cancer cell lines MDA-MB-231 and T47D. Biotechnol Lett 35: 1395-1403.
15. Peddi PF, Ellis MJ, Ma C,. 2012. Molecular basis of triple negative breast cancer and implications for therapy. Int J Breast Cancer 2012: 217185.
16. Rao GN,. 1996. Hydrogen peroxide induces complex formation of SHCGrb2- SOS with receptor tyrosine kinase and activates Ras and extracellular signal-regulated protein kinases group of mitogen-activated protein kinases. Oncogene 13: 713-719.
17. Real PJ, Sierra A, De Juan A, Segovia JC, Lopez-Vega JM, Fernandez-Luna JL,. 2002. Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells. Oncogene 21: 7611-7618.
18. Rodemann HP, Dittmann K, Toulany M,. 2007. Radiation-induced EGFR signalling and control of DNA-damage repair. Int J Radiat Biol 83: 781-791.
19. Selvendiran K, Bratasz A, Tong L, Ignarro LJ, Kuppusamy P,. 2008. NCX- 4016, a nitro derivative of aspirin, inhibits EGFR and STAT3 signaling and modulates Bcl-2 proteins in cisplatin-resistant human ovarian cancer cells and xenografts. Cell Cycle 7: 81-88.
20. Son YO, Hitron JA, Wang X, Chang QS, Pan JJ, Zhang Z, et al., 2010. Cr (VI) induces mitochondrial-mediated and caspase-dependent apoptosis through reactive oxygen species-mediated p53 activation in JB6 Cl41 cells. Toxicol Appl Pharmacol 245: 226-235.
21. Tamura S, Hanada M, Ohnishi M, Katsura K, Sasaki M, Kobayashi T,. 2002. Regulation of stress-activated protein kinase signaling pathways by protein phosphatases. Eur J Biochem 269: 1060-1066.
22. Tassone P, Tagliaferri P, Perricelli A, Blotta S, Quaresima B, Martelli ML, Goel A, Barbieri V, Costanzo F, Bol CR, Venuta S,. 2003. BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells. Br J Cancer 88: 1285-1291.
23. Yip KW, Reed JC,. 2008. Bcl-2 family proteins and cancer. Oncogene 27: 6398-6406.
24. Zandi R, Larsen AB, Andersen P, Stockhausen MT, Poulsen HS,. 2007. Mechanisms for oncogenic activation of the epidermal growth factor receptor. Cell Signal 19: 2013-2023.